HIV Lipodystrophy Syndrome Completed Phase 0 Trials for Streptococcus pneumoniae type 2 capsular polysaccharide antigen (DB10320)

Also known as: Lipodystrophy Syndrome, HIV / HIV-Associated Lipodystrophy / HIV Associated Lipodystrophy / HIV-Associated Lipodystrophy Syndrome / HIV Associated Lipodystrophy Syndrome / Lipodystrophy Syndrome Related to HIV Infection / HIV Lipodystrophy

IndicationStatusPhase
DBCOND0029932 (HIV Lipodystrophy Syndrome)Completed0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03039491Immune Response to Pneumococcal Vaccination in Aging HIV Positive AdultsPrevention